Drawing for GALLIXA

USPTO serial 78894611

GALLIXA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ROSSMAN, WILLIAM M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GALLIXA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, and pharmaceuticals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations namely,appetite suppressants; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics for human use; Pharmaceuticals, namely, lipid lowering agents; all of the foregoing shall be exclusively for human useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 6, 2011MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 6, 2011ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 5, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 4, 2010EX5GSOU EXTENSION 5 GRANTED—
Nov 3, 2010EXT5SOU EXTENSION 5 FILED—
Nov 3, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 5, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 4, 2010EX4GSOU EXTENSION 4 GRANTED—
May 3, 2010EXT4SOU EXTENSION 4 FILED—
May 3, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 4, 2009EX3GSOU EXTENSION 3 GRANTED—
Nov 2, 2009EXT3SOU EXTENSION 3 FILED—
Nov 2, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 19, 2009EX2GSOU EXTENSION 2 GRANTED—
May 19, 2009AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 4, 2009EXT2SOU EXTENSION 2 FILED—
May 4, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 5, 2008EX1GSOU EXTENSION 1 GRANTED—
Nov 5, 2008EXT1SOU EXTENSION 1 FILED—
Nov 5, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 6, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 21, 2008TMBNTTAB RELEASE CASE TO TRADEMARKS—
Mar 21, 2008OP.TOPPOSITION TERMINATED NO. 999999—
Mar 21, 2008OP.DOPPOSITION DISMISSED NO. 999999—
Jan 7, 2008MAILPAPER RECEIVED—
Jun 29, 2007OP.IOPPOSITION INSTITUTED NO. 999999—
Jan 26, 2007ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 2, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 13, 2006NPUBNOTICE OF PUBLICATION—
Nov 14, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 3, 2006ALIEASSIGNED TO LIE—
Oct 27, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 27, 2006DOCKASSIGNED TO EXAMINER—
Jun 2, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance